These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
351 related articles for article (PubMed ID: 23136410)
1. Impaired autophagy in neurons after disinhibition of mammalian target of rapamycin and its contribution to epileptogenesis. McMahon J; Huang X; Yang J; Komatsu M; Yue Z; Qian J; Zhu X; Huang Y J Neurosci; 2012 Nov; 32(45):15704-14. PubMed ID: 23136410 [TBL] [Abstract][Full Text] [Related]
3. Tsc2 gene inactivation causes a more severe epilepsy phenotype than Tsc1 inactivation in a mouse model of tuberous sclerosis complex. Zeng LH; Rensing NR; Zhang B; Gutmann DH; Gambello MJ; Wong M Hum Mol Genet; 2011 Feb; 20(3):445-54. PubMed ID: 21062901 [TBL] [Abstract][Full Text] [Related]
4. Dysregulation of autophagy in melanocytes contributes to hypopigmented macules in tuberous sclerosis complex. Yang F; Yang L; Wataya-Kaneda M; Hasegawa J; Yoshimori T; Tanemura A; Tsuruta D; Katayama I J Dermatol Sci; 2018 Feb; 89(2):155-164. PubMed ID: 29146131 [TBL] [Abstract][Full Text] [Related]
5. Vigabatrin inhibits seizures and mTOR pathway activation in a mouse model of tuberous sclerosis complex. Zhang B; McDaniel SS; Rensing NR; Wong M PLoS One; 2013; 8(2):e57445. PubMed ID: 23437388 [TBL] [Abstract][Full Text] [Related]
6. Regulation of YAP by mTOR and autophagy reveals a therapeutic target of tuberous sclerosis complex. Liang N; Zhang C; Dill P; Panasyuk G; Pion D; Koka V; Gallazzini M; Olson EN; Lam H; Henske EP; Dong Z; Apte U; Pallet N; Johnson RL; Terzi F; Kwiatkowski DJ; Scoazec JY; Martignoni G; Pende M J Exp Med; 2014 Oct; 211(11):2249-63. PubMed ID: 25288394 [TBL] [Abstract][Full Text] [Related]
7. Complex Neurological Phenotype in Mutant Mice Lacking Tsc2 in Excitatory Neurons of the Developing Forebrain(123). Crowell B; Lee GH; Nikolaeva I; Dal Pozzo V; D'Arcangelo G eNeuro; 2015; 2(6):. PubMed ID: 26693177 [TBL] [Abstract][Full Text] [Related]
8. Cerebral vascular and blood brain-barrier abnormalities in a mouse model of epilepsy and tuberous sclerosis complex. Guo D; Zhang B; Han L; Rensing NR; Wong M Epilepsia; 2024 Feb; 65(2):483-496. PubMed ID: 38049961 [TBL] [Abstract][Full Text] [Related]
9. Mammalian target of rapamycin (mTOR) pathways in neurological diseases. Wong M Biomed J; 2013; 36(2):40-50. PubMed ID: 23644232 [TBL] [Abstract][Full Text] [Related]
10. Tumorigenesis in tuberous sclerosis complex is autophagy and p62/sequestosome 1 (SQSTM1)-dependent. Parkhitko A; Myachina F; Morrison TA; Hindi KM; Auricchio N; Karbowniczek M; Wu JJ; Finkel T; Kwiatkowski DJ; Yu JJ; Henske EP Proc Natl Acad Sci U S A; 2011 Jul; 108(30):12455-60. PubMed ID: 21746920 [TBL] [Abstract][Full Text] [Related]
11. Excitatory/inhibitory synaptic imbalance leads to hippocampal hyperexcitability in mouse models of tuberous sclerosis. Bateup HS; Johnson CA; Denefrio CL; Saulnier JL; Kornacker K; Sabatini BL Neuron; 2013 May; 78(3):510-22. PubMed ID: 23664616 [TBL] [Abstract][Full Text] [Related]
12. Hyperactivation of mammalian target of rapamycin complex 1 (mTORC1) promotes breast cancer progression through enhancing glucose starvation-induced autophagy and Akt signaling. Chen Y; Wei H; Liu F; Guan JL J Biol Chem; 2014 Jan; 289(2):1164-73. PubMed ID: 24275666 [TBL] [Abstract][Full Text] [Related]
13. Mechanistic target of rapamycin (mTOR) in tuberous sclerosis complex-associated epilepsy. Curatolo P Pediatr Neurol; 2015 Mar; 52(3):281-9. PubMed ID: 25591831 [TBL] [Abstract][Full Text] [Related]
14. Rapamycin prevents epilepsy in a mouse model of tuberous sclerosis complex. Zeng LH; Xu L; Gutmann DH; Wong M Ann Neurol; 2008 Apr; 63(4):444-53. PubMed ID: 18389497 [TBL] [Abstract][Full Text] [Related]
15. Tuberous sclerosis complex activity is required to control neuronal stress responses in an mTOR-dependent manner. Di Nardo A; Kramvis I; Cho N; Sadowski A; Meikle L; Kwiatkowski DJ; Sahin M J Neurosci; 2009 May; 29(18):5926-37. PubMed ID: 19420259 [TBL] [Abstract][Full Text] [Related]
16. Neurofibromatosis-1 regulates mTOR-mediated astrocyte growth and glioma formation in a TSC/Rheb-independent manner. Banerjee S; Crouse NR; Emnett RJ; Gianino SM; Gutmann DH Proc Natl Acad Sci U S A; 2011 Sep; 108(38):15996-6001. PubMed ID: 21896734 [TBL] [Abstract][Full Text] [Related]
18. ER stress negatively regulates AKT/TSC/mTOR pathway to enhance autophagy. Qin L; Wang Z; Tao L; Wang Y Autophagy; 2010 Feb; 6(2):239-47. PubMed ID: 20104019 [TBL] [Abstract][Full Text] [Related]
19. Postnatal reduction of tuberous sclerosis complex 1 expression in astrocytes and neurons causes seizures in an age-dependent manner. Zou J; Zhang B; Gutmann DH; Wong M Epilepsia; 2017 Dec; 58(12):2053-2063. PubMed ID: 29023667 [TBL] [Abstract][Full Text] [Related]
20. Aberrant mTOR/autophagy/Nurr1 signaling is critical for TSC-associated tumor development. Wang Y; Li C; Zhang Y; Zha X; Zhang H; Hu Z; Wu C Biochem Cell Biol; 2021 Oct; 99(5):570-577. PubMed ID: 34463540 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]